Recent advancements in COPD treatments are providing patients with potential new first-line treatments. Pharmaceutical ...

The recent clinical study update from Regeneron Pharmaceuticals and Sanofi focuses on the investigation of Itepekimab, an anti-IL-33 monoclonal antibody, to understand its effects ...

But if excessive coughing and wheezing are part of your everyday life, you may have chronic obstructive pulmonary disease (COPD). Since this is a progressive disease, having a COPD treatment plan ...

Market Implications: This study could significantly impact AstraZeneca’s stock performance and investor sentiment, as positive results may enhance the company’s COPD treatment portfolio. Competitors ...

Your doctor may first check how you use Ohtuvayre to make sure you are using it properly. If Ohtuvayre does not work for you, you can discuss other treatment options for your COPD with your doctor.

Findings showed in the overall population, treatment with tezepelumab led to a 17% reduction (90% CI, -6, 36; P =.1042) in the annual rate of moderate to severe COPD exacerbations compared with ...

First new treatment in a decade There haven’t been any new advancements in COPD maintenance therapies for more than a decade, leaving the patients who still feel symptoms eager for new options.

Supporting rural and other healthcare providers to improve COPD care, better understand COPD treatment options, and build strong, trusting relationships with their patients.

CENTER VALLEY, Pa., Nov. 13, 2024 /PRNewswire/ -- During COPD Awareness Month, Olympus Corp. of the Americas is celebrating strides in emphysema treatment and working with groups like ...

CHICAGO, July 8, 2025 /PRNewswire/ -- The American Lung Association is launching a new campaign to support and empower individuals living with chronic obstructive pulmonary disease (COPD) in rural and ...